Treatment of infantile primary pulmonary hypertension by intravenous infusion of lipo-prostaglandin I2 analog.
We used a new vasodilator, TTC-909 (a prostaglandin I2 analog incorporated in lipid microspheres), which produced marked reduction in the pulmonary arterial pressure and resistance in an infant with primary pulmonary hypertension.